Tau-PET imaging allows the detection of tauopathy and highly predicts subsequent cognitive decline in both asymptomatic and symptomatic individuals (Leuzy et al., 2019; Wang and Edison, 2019; Beyer and Brendel, 2021). Here, MAPT is linked to tauopathy.